In drug development, it is important to maximize business value by gradually implementing lifecycle strategies such as expanding disease areas, extending patents, and even expanding to best-in-class products, starting with a single success (POC*2). As a pioneer in the development of LATl inhibitors, we have achieved POC in biliary tract cancer and are already embarking on the next lifecycle strategy. By promoting these initiatives in collaboration with our own R&D partners and business partners, we aim to create sustainable and significant business value.

注：当社の事業戦略に関するイメージ図であり、実際の事業展開とは異なる可能性がある

•2 POC (Proof of Concept) refers to the concept and verification process used to demonstrate the feasibility of a hypothesis or new treatment at an early stage in research and development. In drug discovery, it is an important milestone in the early stages of clinical trials (mainly Phase 2 trials) to determine whether a new drug candidate actually works for patients and whether to continue development.